Surgical Equipment Market by Key Players, Growth, Regions and Forecast to 2021

marketresearchfuture

A Surgical Equipment is a specially designed tool or device for performing specific actions of carrying out desired effects during a surgery or operation, such as modifying biological tissue, or to provide access for viewing it. Over time, many different kinds of Surgical Equipment s and tools have been invented. Some Surgical Equipment s are designed for general use in surgery, while others are designed for a specific procedure or surgery. Accordingly, the nomenclature of Surgical Equipment s follows certain patterns, such as a description of the action it performs (for example, scalpel, and hemostat), the name of its inventor(s) (for example, the Kocher forceps) or a compound scientific name related to the kind of surgery. The Surgical Equipment Market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.

Global Surgical Equipment Market– Forecast to 2021 The report firstly introduced Global Surgical Equipment Market including classification, application and industry chain overview; Then we deeply analyzed global growth forecast indicators by the as well as the regional market conditions that including the product price, profit, utilization, supply, demand and industry growth rate etc.

In the end, the report introduced Surgical Equipment market SWOT analysis, PEST analysis, market share analysis and competitive landscape, company profiles by analyzing the major players. It is a depth research study on Global Surgical Equipment Market. We are thankful for the support and assistance from Global Surgical Equipment Market. Industry chain related technical experts and marketing experts during Research Team survey and interviews.

The report for Global Surgical Equipment Industry of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions

Brief TOC

  1. Introduction
  2. Research Methodology
  3. Report Excerpt
  4. Forecast Indicators
  5. Market Analysis
  6. Global Surgical Equipment Market, By Type
  7. Geographical Explorations
  8. Competitive Analysis
  9. Company Profiles
  10. Appendix

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand,

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Shivkumar is a Digital Marketer by professional and he has a great experience in blogging, content writing and SEO

Safety Lancet Market-Outlook, Regulatory Bodies, Trends, Industry Insights & Forecast

marketresearchfuture

Safety lancet is a disposable contrivance used for collecting capillary blood samples by doctors or other medical professionals. This is an intact object to the prevention from needle injury problems. Safety lancet eradicates the injuries and infections caused by injections. The global Safety Lancet Market is projected to reach USD 2,305.1 million in 2023 from USD 1,056.2 million in 2016 with a CAGR of 11.8% during the forecast period 2017-2023.

The cost of safety lancet is really high. So as a result though it is painless and hazardless people from undeveloped countries can’t afford them. Countries like Africa where there is scarcity of food people can’t even think about adopting this new innovative technology. Other than this another factor demolishing the market growth of safety lancet is that it is not always available. This availability problem is somehow hindering the growth of Safety Lancet Market.

Safety Lancet Market-Overview:

Various reasons are helping behind the grand success of safety lancet market. The safety lancet becomes automatically inactive after it is used once. So there is no way to use it twice. This helps the doctors to maintain proper hygiene needed for the patient as a result patients are highly demanding for the use of safety lancet which is further propelling the market growth. Safety lancet contains self-retracting needles which reduces the hazard of cross contamination and other needle related injuries. Safety lancet is created in a way that it goes slightly under the skin and pulls as much of blood is required without leaving some deep injuries inside the skin. This is a great option for those who has fear in needle, as a result hospitals are hugely adopting this safety lancet.  Another aspect helping the acceptance of safety lancet in market is that this has high speed penetration which helps to abbreviate the pain which comes from regular injections. The sharp injury prevention aspect of safety lancet is expanding its market growth globally.

Safety Lancet Market- Regional Analysis:

Asia Pacific has countries like India, China where high population is giving rise to the adoption of safety lancet. South Korea has done some huge advancement which is working as a reason behind the huge growth of Safety Lancet Industry in Asia Pacific.

North America is massively contributing in the market growth of safety lancet market. Health care clinics and hospitals in US are considerably adopting this new medical technology as patients over there are highly aware about hygiene. Europe is also contributing in the market growth of safety lancet. Germany, France and Italy are embracing this safety lancet in their hospitals and clinics.

Safety Lancet Market-Competitive Analysis:

In 2007, GMMC chucked the LANZO lancing device and in 2011 GMMC initiated LANZO safety lancet and is recognized among the best suppliers of safety lancet in Korean market.

Major contributors in this market are: F. Hoffmann-La Roche AG, Becton, Dickinson and Company, Terumo Medical Corporation, Bayer AG, HTL-STREFA S.A., Sarstedt AG & Co., Improve Medical Technology Co. Ltd and others.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand,

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Shivkumar is a Digital Marketer by professional and he has a great experience in blogging, content writing and SEO

Next-Generation IV Infusion Pumps Market is Anticipated to Collect of US$ 3.2 Bn by 2025 End

Persistence Market Research has carried out a detailed market research on next-generation IV infusion pumps and has presented vital insights based on the market analyses in its research publication titled “Next-Generation IV Infusion Pumps Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025)”. This research report covers various macro-economic aspects influencing the growth of the next generation IV infusion pumps market along with various trends, opportunities, restraints and drivers impacting the market. These impacting factors are scrutinized across important regions considering all major market segments.

The global next-generation IV infusion pumps market has been thoroughly analyzed and is anticipated to grow at a robust CAGR of 5.4% throughout the period of forecast 2017-2025. The global market is estimated to reach a value of about US$ 3.2 Bn in 2025 from a value of around US$ 2 Bn in 2016. This market has witnessed a positive growth path since 2012 and it is poised to continue over the following years.

Expanding production base for smart PCA, ambulatory and syringe pumps in developing economies and rising adoption of smart pumps with huge drug libraries are opportunities that can be tapped by players involved in the global next-generation IV infusion pumps market. Emerging economies offer high opportunities as they register high rate of spread of chronic diseases. The advancements in IV infusion pumps systems, increasing research and development infrastructure due to rising investments and expenditure on research and development, favorable reimbursement for infusion therapy, rising demand for ambulatory infusion pumps, increasing strategic collaborations among leading players, improvement in distribution channel, ease in FDA approvals and clearance, strong government support for start-ups, expanding production capacity and extension of product line coupled with expanding medical device infrastructure and growing adoption of advanced medical devices have strongly supported the growth of the next-generation IV infusion pumps market. Medicine dispensing errors, product recalls due to product errors, lack of skilled personnel and lack of standard usage guidelines are few aspects which pull the adoption of next-generation IV infusion pumps thus having a negative impact on the global next-generation IV infusion pumps market.

The global next-generation IV infusion pumps market has been categorized by product type, by application, by end user and by region.

  • By region, Asia Pacific is expected to witness high growth as compared to other regions, and is poised to reach a significant market share with a high CAGR of 7.8% throughout the period of forecast 2017-2025. North America region stays ahead with respect to market value to dominate the global next-generation IV infusion pumps market by region followed by Europe
  • Chemotherapy segment by application is the fastest growing segment and is expected to reflect high market valuation by the end of 2025. This segment is projected to grow at a CAGR of 7.1% throughout the forecast period to attain an estimated value of about US$ 1.1 Bn in 2025
  • Hospitals segment by end user dominates the global market and also poised to reflect a high CAGR of 6.0% during the assessment period due to rise in adoption of infusion pumps in hospitals
  • Large volumetric infusion systems to lead the global next-generation IV infusion pumps market by product type to reach a market value of about US$ 1.1 Bn in 2025. Electronic ambulatory infusion systems product segment is poised to show high potential in the coming years

The global next-generation IV infusion pumps market research report covers key players involved in the  market such as B. Braun Melsungen AG., Becton, Dickinson Company, Fresenius Kabi AG, Terumo Corporation, Medtronic Plc., Baxter International Inc., Hospira, Inc., iRadimed Corporation, Zyno Medical, Nipro Corporation, Ambu A/S, Summit Medical Products, Inc., Smiths Medical, vTitan and Gamastech s.r.l.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

Neurointerventional Devices Market to Report a CAGR of 4.8% Between 2015 and 2025

futuremarketinsights_logo

Future Market Insights (FMI), in its latest report titled, “Neurointerventional Devices Market: Global Industry Analysis and Opportunity Assessment 2015 – 2025”, has projected global neurointerventional devices market to expand at a CAGR of 4.8% during the forecast period (2015-2025).

As per the Society of Neurointerventional Surgery, neurointervention is a treatment approach to conditions occurring within the blood vessels of the brain or in the spinal cavity. This procedure is highly performed by neuro-specialists due to its safety, minimally-invasive technique and comparatively higher success rate ratio as compared to conventional clipping method.

Global neurointerventional devices market is estimated to account for US$ 1,766.8 Mn by the end of 2015, mainly driven by rising demand from end-use segments.

The report analyses the global neurointerventional devices market in terms of market value (US$ Mn) and market volume (units) by product type, region, end-user and technique, and provides information regarding market dynamics, regulatory compliances, competitive landscape, current trends, market estimations and forecast for the market.

Adoption rate of neurointervention devices among neurosurgeons/neuro-specialists has increased significantly owing to the technological advancements and benefits these devices offer. These devices, especially metal coils and catheters, are highly preferred by neurosurgeons. Increasing geriatric population globally is also expected to boost overall demand for neurointerventional devices. These devices find wide application in Japan and countries in developed regions such as Western Europe and North America. However, these devices are expected to gain popularity in Latin America and Asia Pacific excluding Japan (APEJ) in the near future. High cost along with negative perception about certain neurointervention devices are factors that are expected to act as growth restraints in the future, and some devices approval by FDA have also faced criticism for performance.

North America is expected to dominate the global market throughout 2025 and is projected to witness 1.6X increase in volume over the forecast period. The U.S is expected to dominate the North America neurointerventional devices market throughout the forecast period. However, the U.S. market is projected to lose significant amount of its market value share to Canada by the end of forecast period. North America is a major neurovascular market. The region is expected to witness launch of various new products, with increasing number of players expected to enter into the market over the following five years. Japan is the next most lucrative market for neurovascular companies; however, the market in the region is projected to witness below average CAGR of 3.9% during the forecast period.

Among product types, embolic coils product segment is expected to dominate the global neurointerventional devices market, followed by the neurothrombectomy product segment. Increasing incidence of brain aneurysm is expected to boost overall demand for embolic coils albeit, at a comparatively lower pace. Flow diverters and stent retrievers are gaining wide recognition among neurointerventionists. Stent retrievers segment is expected to witness impressive growth in the U.S. market over the following five years. Global stent retrievers segment is expected to witness 2X increase in value over the forecast period.

On the basis of technique, neurointervention devices market is segmented into neurothrombectomy procedure, cerebral angiography, stenting, coiling procedures and flow disruption. Coiling procedure segment is expected to dominate the overall neurointerventional devices market by the end of forecast period. The segment is projected to register average growth rate over the forecast period. Flow disruption is projected to be the fastest growing procedure segment. Increasing adoption of flow diverters among neurointervention is fuelling growth of the procedure segment.

On the basis of end use, the market has been segmented into hospitals and ambulatory surgical centers. Hospitals segment accounts for major share of the neurointerventional devices market.

Key market participants covered in the report include Medtronic, Penumbra Inc., Stryker Corporation, Terumo Corporation, and Johnson & Johnson.

About Us 

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.

Contact Us

616 Corporate Way, Suite 2-9018,

Valley Cottage, NY 10989,

United States

T: +1-347-918-3531

F: +1-845-579-5705

T (UK): +44(0)20-7692-8790

Sales: sales@futuremarketinsights.com

Smita Deshmukh is a veteran digital marketing professional, having worked for numerous online firms in his distinguished career. She believes in continuous learning, considering that the digital marketing sector’s rapidly evolving nature.

8 Predictions on how Ultrasound Systems Market will Expand through 2022

Due to the increasing adoption of advanced imaging systems in healthcare industry, ultrasound systems continue to be an irreplaceable commodity. In the view of rising healthcare costs, affordable and accurate imaging & diagnosis achieved through ultrasound technology will continue to attract patients, and render profits even in conventional medical settings. Fact.MR’s report on the global market for ultrasound systems projects a steady growth for the market during 2017-2022. The global ultrasound systems market, which is pegged to reach US$ 6 Bn by 2017-end, will soar steadily at a 5.5% CAGR to reach US$ 7.8 Bn towards the end of 2022.

Following are key projections on the global ultrasound systems market, excerpted from the report:

  1. The report highlights the application of ultrasound systems in cardiology. Alarming rise in incidence of cardiac disorders throughout the globe is expected to drive the adoption of ultrasound systems, which are effectively used in cardiology diagnostics. Between 2017 and 2022, more than US$ 430 Mn worth of incremental opportunity will be created by application of ultrasound systems in cardiology. The report also predicts that nearly half of ultrasound systems sold in the global market during the forecast period will be developed on 2D ultrasound imaging technology.
  2. Healthcare infrastructure in developed economies such as the US and Canada is expected to promote the adoption of ultrasound systems. The report projects that by the end of 2022, North America’s ultrasound systems market will have reached an estimated value of US$ 3.2 Bn. During this forecast period, North America is also anticipated to be the largest market for ultrasound systems in the world.
  3. The report also observes impressive growth in the ultrasound systems market across European countries. In 2017, more than 25% of the global ultrasound systems market value is expected to be accounted by sales of ultrasound systems in Europe.
  4. Demand for ultrasound systems in the Asia-Pacific excluding Japan (APEJ) region is projected to be lower than above regions, however, manufacturers will be interested in laying down their production units in this region. In such manner, the APEJ ultrasound systems market is likely to account for more than 15% of the global market revenues throughout the forecast period.
  5. Based on the portability of ultrasound systems, the report expects a higher demand for standalone systems. By procuring revenues worth US$ 4.2 Bn, standalone ultrasound systems will dominate the global market with more than 70% revenue share towards the end of 2017. On the other hand, portable ultrasound systems will showcase a robust revenue growth at 6.4% CAGR, albeit, reflecting a little over 17% share on the global ultrasound systems market.
  6. Hospitals will remain the largest end-users of ultrasound systems in the global market, and account for half of its value in the years to come. Meanwhile, diagnostic centers will contribute to nearly 20% of the global ultrasound systems market, procuring revenues worth US$ 1.6 Bn by 2022-end.

The report has profiled leading players in the global ultrasound systems market, which include companies namely, General Electric Company, Koninklijke Philips N.V., Toshiba Corporation, Siemens AG, Hitachi Ltd., Fujifilm Holdings Corporation, Esaote SpA., Shimadzu Corporation, Analogic Corporation, and Samsung Electronics Co. Ltd.

About Fact.MR       
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com

Yogesh is a Digital Marketer by professional and he has a great experience in blogging, content writing and SEO.

Outpatient Clinics Market Will Likely to Expand at a Steady CAGR of 4.3% by 2027

futuremarketinsights_logo

Growing advancements in medical technology has led to development of treatment techniques and medications that do not require the patients to stay for long hours at the clinics or hospitals. However, imposition of strict regulations will continue to hinder the global market growth of outpatient disorders over the forecast period. Future Market Insights states that the global market of outpatient clinics is projected to reflect a CAGR of 4.3%, representing more than US$ 39,000 Mn by 2022-end.

Factors Fuelling Global Market Growth

Growth of the global outpatient clinics market is mainly bound to various macro-economic and micro-economic factors. Prevalence of chronic diseases such as asthma, diabetes, depression and congestive heart failures lead to complex and severe health problems. With the escalating cost of treatment process in various healthcare organizations, patients prefer visiting the outpatient clinics for accessing treatment. Growing concerns regarding the increasing prevalence of cardiovascular diseases such as elevated blood pressure levels, hypertension, coronary heart diseases and cerebrovascular diseases has further led to surge in demand for the outpatient clinics globally.

Demand for quick and effective treatment of cardiovascular diseases will continue to contribute towards the global market growth of outpatient disorders. According to a recently published report by CDC, nearly 610,000 people die of heart attack in the U.S. each year, which is 1 in every 4 deaths. As cardiovascular diseases continue to remain a leading cause of mortality globally, demand for effective and quick treatment process will continue to remain high. These factors are projected to impact the global market growth of outpatient clinics throughout the forecast period.

Collaborations among the private insurance companies and outpatient clinics will continue to remain a major trend in the global market. Through collaborations the private insurance companies offer payment and services in outpatient clinics. Imposition of regulations such as Health Care and Educational Reconciliation Act and Patient Care Affordable Act provides the U.S. citizens with the public health insurance coverage and offers access to private health insurance services. Moreover, increasing employee benefits such as Employees’ health insurance by the employers is projected to contribute towards the global market growth of outpatient clinics over the forecast period.

However, the global market of outpatient clinics will continue to witness inhibiting growth attributed to various factors. Imposition of strict regulations and limited number of doctors for the treatment of various diseases will remain a key factor inhibiting demand for services offered by outpatient clinics. As the patients are not monitored for a long period of time, risk of addiction to alcohol and drugs is projected to remain high. Moreover, lack of access to counselors in comparison to the residential and inpatient facility is further projected to impede the global market growth of outpatient clinics.

Sales to Remain High Through Cardiology Specialty Areas

Prevalence of chronic and cardiovascular disorders is projected to fuel demand for the multi-specialty centers globally. In terms of revenue, the multi-specialty center type segment is projected to witness significant growth, representing more than US$ 8,400 Mn by 2022-end. Moreover, the multi-specialty center type segment is projected to reflect the fastest growth in the global market of outpatient clinics throughout the forecast period.

On the basis of specialty type, the dermatology segment is projected to reflect a significant CAGR through 2022. However, the cardiology specialty areas segment is projected to represent a robust revenue growth, recording more than US$ 3,000 Mn over the forecast period.

Market Players

Major players in the global market of outpatient clinics are Kaiser Permanente Inc., M D Anderson Cancer Center, Mayo Clinic, Memorial Sloan Kettering, University of Maryland Medical Center, DaVita Inc., Cleveland Clinic, Fresenius Medical Care and Johns Hopkins Medicine.

About Us 

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.

Contact Us

616 Corporate Way, Suite 2-9018,

Valley Cottage, NY 10989,

United States

T: +1-347-918-3531

F: +1-845-579-5705

T (UK): +44(0)20-7692-8790

Sales: sales@futuremarketinsights.com

Smita Deshmukh is a veteran digital marketing professional, having worked for numerous online firms in his distinguished career. She believes in continuous learning, considering that the digital marketing sector’s rapidly evolving nature.

5 Key Takeaways from Fact.MR’s Report on Prostate Cancer Diagnostics Market

According to the latest report by Fact.MR, the global prostate cancer diagnostics market is anticipated to exhibit a steady expansion at 5.3% CAGR during the forecast period 2017 to 2022. In terms of revenues, the market is projected to reach US$ 823.5 Mn in 2017; by 2022 this number is projected to surpass US$ 1,000 Mn.

Diagnosis of prostate cancer is becoming a critical undertaking for medical organizations. Newer treatments on prostate cancer are being developed by considering the scope of diagnostic approach. This emergence of diagnosis-associated treatments on prostate cancer is expected to render higher medical efficiency, providing effective outputs at minimal healthcare spending. Through and through, medical organizations are scanning key criteria associated with diagnosis of prostate cancer, tracking parameters such as age of the patient, ethnicity, family medical history, and diet. Considering the sensitivity of organs in the prostate area, patients are also adopting non-invasive diagnosis tests, which is ultimately impacting the products sold in the global market for prostate cancer diagnostics.

Advancements in technology for finding newer techniques for treatment & diagnostics of prostate cancer, changing lifestyles of people across the globe, and the rise in funding from both private as well as public sector in the development of drugs are some factors influencing growth of the global market for prostate cancer diagnostics. Serum-based market testing is being widely adopted for prostate cancer diagnostics. In order to enhance the test’s sensitivity, it is being evaluated with several other cancer-specific markers. However, risks related to overtreatment and over-diagnosis of PSA screening is expected to incur challenges to growth of the global prostate cancer diagnostics market. However factors such as, high cost of treatment, surgical-associated risks such as blood clots, strokes, and heart attacks, and surgical side effects such as urinary incontinence & impotence are expected to curb growth of the market over the forecast period.

5 Estimations from Fact.MR’s Report on the Global Prostate Cancer Diagnostics Market

  1. North America will continue to be the most lucrative region in the global prostate cancer diagnostics market, in terms of revenues. The prostate cancer diagnostics market in North America and Europe are expected to exhibit similar CAGRs through 2022.
  2. The market in Asia-Pacific excluding Japan (APEJ) is expected to register the fastest expansion through 2022. In contrast, prostate cancer diagnostics market in Middle East & Africa will continue to register a sluggish expansion during the forecast period.
  3. PSA tests will continue to be the largest adopted tests for diagnosis of prostate cancer across the globe. PSA test segment is projected to register the highest CAGR in the market through 2022.
  4. Hospital-associated labs are expected to remain the largest end-users of prostate cancer diagnostics in the global market, however revenues from prostate cancer diagnostics in hospital-associated labs will register the lowest CAGR in the market through 2022.
  5. In terms of revenues, cancer research institutes are expected to register the highest CAGR in the market through 2022. Independent diagnostics labs will remain the second largest end users of the prostate cancer diagnostics during the forecast period.

The report has also profiled key players in the global market for prostate cancer diagnostics, which include Abbott Laboratories, AstraZeneca plc., Bayer Aktiengesellschaft, Danaher Corporation, Becton, Dickinson and Company, Foundation Medicine, Inc., Cancer Genetics, Inc., Myriad Genetics Inc., Agilent Technologies, and Biocept, Inc.

About Fact.MR       
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com

Yogesh is a Digital Marketer by professional and he has a great experience in blogging, content writing and SEO.

Global Spinal Cord Trauma Treatment Market Estimated to Exhibit of US$ 3,036.2 Mn by 2025

“Spinal Cord Trauma Treatment Market: Global Industry Analysis 2012 – 2016 and Forecast 2017 – 2025” is the recent report of Persistence Market Research that throws light on the overall market scenario during the period of eight years, i.e. 2017-2025. According to this report, Global spinal cord trauma treatment market is expected to witness significant growth during the forecast period. This growth is expected to be primarily driven by increasing incidence of spinal cord trauma, and increasing government support to reduce the burden of spinal cord injuries. Additionally, development of nerve cells growth therapy is expected to boost the market in near future. The global market for spinal cord trauma treatment is is estimated to be valued at US$ 2,276.3 Mn in terms of value by the end of 2017. The global spinal cord trauma treatment market is expected to expand at a CAGR of 3.7% over the forecast period to reach a value of US$ 3,036.2 Mn by 2027 end.

Global Spinal Cord Trauma Treatment Market: Trends

  • Medical tourism for post spinal surgery rehabilitation
  • Research on neuroregeneration therapies
  • Increasing use of mechanical spinal traction
  • Focus towards improvement of quality of life by increasing the use of robot assisted rehabilitation
  • Methylprednisolone as a standard corticosteroid therapy
  • Public private partnership for better health infrastructure and work as a source to meet the funding gap
  • Increasing cases of vehicle accidents
  • Development of stem cell therapy

On the basis of end user, the global spinal cord trauma treatment market is segmented into hospitals and trauma centers. Hospitals segment dominated the global spinal cord trauma treatment market in revenue terms in 2016 and is projected to continue to do so throughout the forecast period. Hospitals and trauma centers segments are expected to approximately similar attractive index. Hospitals segment accounted for 53.2% value share in 2017 and is projected to account for 52.5% share by 2025 end.

On the basis of injury type, the global spinal cord trauma treatment market is segmented into complete spinal cord injuries and partial spinal cord injuries. Partial spinal cord trauma treatment segment is expected to show better growth than the completed spinal cord treatment segment due to higher growth in the incidence rate of partial spinal cord trauma than the complete spinal cord trauma. With US$ 1,870.3 Mn market value in 2025, this segment is likely to expand at CAGR 3.8% throughout the projected period.

On the basis of treatment type, the global spinal cord trauma treatment market is segmented into corticosteroid, surgery, and spinal traction segments. Surgery segment dominated the global spinal cord trauma treatment market in revenue terms in 2016 and is projected to continue to do so throughout the forecast period. Surgery segment is the most attractive segment, with attractiveness index of 2.6 over the forecast period.

This market is segmented into five regions such as North America, Latin America, Europe, APAC and MEA. Asia-Pacific account for the largest market share in the global spinal cord trauma treatment market. Large patient population due to the high rate of road accidents and crime is making the Asia Pacific region most attractive market for spinal cord trauma treatment. On the other hand, MEA and Latin America is expected to be the least attractive market for spinal cord trauma treatment, with attractiveness index of 0.3 and 0.5 respectively over the forecast period.

Acorda Therapeutics, Inc., Asterias Biotherapeutics, ReNetX Bio, BioArctic AB, BioTime, Inc., InVivo Therapeutics, Kringle Pharma, Inc., Novartis AG, Pfizer Inc., Pharmicell Co. Ltd., Vertex Pharmaceuticals Inc., and Bioaxone Biosciences, Inc. are some of the key players in the global spinal cord trauma treatment market.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

Explosion Proof Equipment Market revenue will reach $10 billion by 2024

As per the report “Explosion Equipment Market by Industry Vertical (Pharmaceutical, Manufacturing, Marine, Mining,Food Processing, Signaling Devices, Others ), by Applicable System Type (Cable Glands,Junction Boxes & Enclosures, Lifting & Material Handling, Automation System, others),by Equipment Type (Explosion proof, Explosion Prevention, Explosion Segregation) Industry trends, Estimation & Forecast, 2016 – 2024″, the global explosion proof market was valued at $5 billion in 2016, and is projected to reach $10 billion by 2024, growing at a CAGR of 9.2% from 2017 to 2024. In 2016, oil & gas industry segment generated the highest revenue share in the terms of global explosion proof equipment market. Among major regions, North American explosion proof equipment market was the highest revenue generating market valued at $1.6 billion in 2016.

“The increasing need to improve the safety in industrial areas has accelerated the adoption of explosion proof equipment. A sudden rise in the number of explosions occurred in the extreme environment of manufacturing industries due to the presence of chemicals, toxic paints, and other combustible dust has prompted them to increasingly focus on explosion prevention.”

Oil & Gas industry generated the highest revenue of $902 million in 2016 and held nearly 18% share of the total explosion proof equipment market

Oil & gas industry generated the highest revenue in 2016 as a result of wide adoption of explosion-protected products in this sector acting as a preventive measure against explosive areas. The adoption of spark-resistant enclosures, thermocouples, and sensors in hazardous areas of oil & gas industry can eliminate the release of potential flammable substances. Thus, it is expected to dominate other segments growing with the highest CAGR of 10.1% during the forecast period of 2017-2024. The manufacturing segment follows the oil & gas segment generating a revenue of $780 million in 2016 owing to the emerging manufacturing firms all over the globe.

Explosion Prevention equipment market lead the global explosion proof equipment market in 2016 growing with a CAGR of 9.9 % during the forecast period

The explosion prevention equipment market generated a revenue of $2.3 billion in 2016 and is expected to lead the market for the entire forecast period. This is a result of high adoption of explosion prevention equipment in hazardous locations and increased safety and better productivity of industries. For instance, food processing industries largely use this technology. Sugar dust explosion can generate a pressure in excess of 100 psi within enclosed process equipment in less than 100 milliseconds. Hence, industries are now provided with recently updated tools to manage such risk in accordance with government rules and regulations.

North America generated the highest revenue in terms of explosion proof equipment market in 2016

Across the globe, the market is segmented into North America, Europe, Asia-Pacific, and Rest of World. Among the major geographies North America generated the maximum revenue in the global market, accounting for more than 31% share in 2016, owing to high adoption and production of ignition-proof automated solutions. The region generated a revenue of $1.6 billion in 2016 and is expected to grow with a CAGR of 8.3% during the forecast period.

However, Asia-pacific explosion proof equipment market is expected to witness a impressive growth, having the highest CAGR of 10.4% during the forecast period. The rise of industrialization in Asian countries, especially in India and China are supposed to drive the market for explosion-proof equipment. The mining industry is rapidly growing in India with a pro-industry government. Oil-rich regions like the South China Sea and the Arabian Sea provide a lucrative market for explosion-proof equipment.

Key Findings of Global Explosion Proof Equipment market

    • Oil & Gas industry generated the highest revenue of $902 million in 2016 and held nearly 18% share of the total explosion proof equipment market
• The explosion prevention equipment market generated a revenue of $2.3 billion in 2016 and is expected to lead the market for the entire forecast period
• Asia-pacific explosion proof equipment market is going expected to witness a impressive growth, having the highest CAGR of 10.4% during the forecast period
• North America generated the highest revenue in terms of explosion proof equipment market in 2016

Product launch was the majorly adopted strategy by the top market players, holding nearly half of the total market strategy share. Adalet, a leading manufacturer of explosion-proof enclosure systems, recently launched an explosion-proof combination motor starter, integrated with modular and interchangeable trip blocks. Some major companies of the market are Adalet, Intertek Group Plc, Extronics Ltd, Bartec Group, R. Stahl AG, Pepperl+Fuchs Gmbh, Siemens AG, Rockwell Automation, Inc., Cooper Industries (Eaton), ABB Group, BCom Solutions, Inc. and Honeywell International Inc.

About Us

Esticast Research & Consulting is a research firm providing research reports on various industries with a unique combination of authenticity, extensive research, and infallibility. We provide syndicated market research reports, customization services, and consulting services to help businesses across the world in achieving their goals and overcoming complex challenges. We specialize in providing the 360-degree view of the markets to assist clients in determining new opportunities and develop business strategies for the future with data and statistics on changing market dynamics. Esticast Research & Consulting has expert analysts and consultants with an ability to work in collaboration with clients to meet their business needs and give opportunities to thrive in a competitive world. A comprehensive analysis of industries ranging from healthcare to consumer goods and ICT to BFSI is provided by covering hundreds of industry segments. The research reports offering market forecasts, market entry strategies, and customer intelligence will help clients across the world in harnessing maximum value on their investment and realize their optimum potential.

Contact
Esticast Research & Consulting
410 State Route 57 East,#206, Washington, NJ 07882
Tel: +1-908-379-7709
Email: sales@esticastresearch.com

Flavored Dairy Market Estimated to Flourish by 2024

persistencemarketresearch

The dairy products are produced from the milk of mammals such as cattle, buffalo, goat, sheep, and camel. Flavors are used in the dairy product either to alter or to improve the taste by adding a particular ingredient. Flavored dairy products are the source of calcium and vitamin D, Vitamin B2, B3 and B12. The Milk and Cheese segments are collectively expected to dominate among product type segment of the global flavored dairy market.

Owing to the rise in consumer preference for chocolate, vanilla and strawberry flavors in the dairy products, these three segments are collectively anticipated to lead among the flavor type segment. On the other hand, food and beverage industry is expected to hold maximum market share in terms of value and volume among the end use industry segment. The global flavored dairy market is anticipated to witness significant CAGR during the forecast period.

Factors expected to drive the demand are increasing consumer disposable income, and increase in consumer awareness regarding healthy benefits of the flavored dairy products. Furthermore, change in lifestyles and taste preferences of the consumer is expected to propel the demand for flavored dairy products. Also, growing food and beverage industries is anticipated to fuel the demand for flavored dairy products.

However, reduced milk trade in some countries Argentina and Brazil is expected to limit the growth of the global flavored dairy market.

Based on the geographies, the global flavored dairy market is segmented into five key regions, namely North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Asia pacific is anticipated to hold the maximum market share in terms of revenue among the regions.This is due to the increasing demand for flavored dairy products such as milk, yogurt, buttermilk, shrikhand, and basundi in India, China, and Indonesia. Owing to the presence of the large number of dairy product manufacturers in Switzerland, France, Germany, and the UK, increase in consumer disposable income, and rise in consumer demand for flavored dairy products, the Europe flavored dairy market is expected to witness healthy CAGR over the forecast period. North America is expected to exhibit lucrative growth for flavored dairy market owing to the increase in R&D, production and consumer demand for cheese and yogurt in Canada. The U.S.

dairy industry is sixth largest in the world in terms of milk production, hence it is expected to contribute favorably to the North America flavored dairy market. Latin America and MEA are anticipated to show modest growth rate throughout the forecast period. This is attributed to the rise in health awareness and demand for nutritious and healthy food, and changing lifestyle in Brazil, GCC countries, and South Africa.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology, and applications.